摘要
目的观察复方阿嗪米特与莫沙必利联用对功能性消化不良患者临床症状积分、胃排空试验及容受性的影响。方法选取收治的功能性消化不良患者198例,按照患者自愿选择治疗方案分为观察组与对照组;观察组100例给予复方阿嗪米特与莫沙必利治疗,对照组只给予莫沙必利治疗。均为一个疗程(4周)后比较两组患者效果。结果观察组治疗后的症状积分比对照组低,差异具有统计学意义(P<0.05);观察组和对照组在胃排空延缓、溃疡样型、动力障碍样型、非特异性比较,观察组明显高于对照组,差异均具有统计学意义(P<0.05)。结论复方阿嗪米特肠溶片与莫沙必利联合治疗功能性消化不良,临床效果较好,随治疗时间的延长临床效果更加显著。
Objective To analyze effects of azintamide and mosapride on the symptoms of functional dyspepsia score,gastric emptying test and receptivity and recurrence of functional dyspepsia.Methods 198 patients with functional dyspepsia were divided into control group and observation group.The observation group was treated with azintamide and mosapride.The control group was treated with mosapride.Results The symptom integral of the observation group was lower than that of the control group（P〈0.05）.The delayed gastric emptying,ulcer like type and motility dysfunction of the observation group were higher than that of the control group（P〈0.05）.Conclusion It is effective to treat functional dyspepsia with azintamide and mosapride.
出处
《西部医学》
2015年第7期1013-1015,共3页
Medical Journal of West China
基金
广东省科技厅医药卫生基金项目(2012A030400049)
